Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.
Kayser S, Sartor C, Giglio F, Bruno A, Webster J, Chiusolo P, Saraceni F, Guerzoni S, Pochintesta L, Borlenghi E, Marconi G, Zacheo I, Cerrano M, Salutari P, Restuccia F, Abbenante M, Levis MJ, Schlenk RF, Papayannidis C. Kayser S, et al. Among authors: pochintesta l. Haematologica. 2024 May 1;109(5):1385-1392. doi: 10.3324/haematol.2023.284310. Haematologica. 2024. PMID: 38058184 Free PMC article.
Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure.
Taliani G, Follini E, Guglielmetti L, Bernuzzi P, Faggi A, Ferrante P, Fronti E, Gerna L, Leoni MC, Paolillo F, Ratti G, Ruggieri A, Valdatta C, Donisi A, Zangrandi A, Pochintesta L, Moroni C, Sacchini D, Vallisa D, Codeluppi M; COVID-Piacenza Group. Taliani G, et al. Among authors: pochintesta l. Front Oncol. 2021 Jan 25;10:582901. doi: 10.3389/fonc.2020.582901. eCollection 2020. Front Oncol. 2021. PMID: 33585201 Free PMC article.
Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant.
Mangiacavalli S, Pochintesta L, Ravelli E, Baldini L, Ferretti VV, La Targia ML, Farina L, Cocito F, Cairoli R, Montefusco V, Corso A. Mangiacavalli S, et al. Among authors: pochintesta l. Leuk Lymphoma. 2015 Jun;56(6):1901-2. doi: 10.3109/10428194.2014.979414. Epub 2015 Jan 14. Leuk Lymphoma. 2015. PMID: 25347423 Clinical Trial. No abstract available.
MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.
Varettoni M, Zibellini S, Arcaini L, Boveri E, Rattotti S, Pascutto C, Mangiacavalli S, Gotti M, Pochintesta L, Paulli M, Cazzola M. Varettoni M, et al. Among authors: pochintesta l. Blood. 2013 Sep 26;122(13):2284-5. doi: 10.1182/blood-2013-07-513366. Blood. 2013. PMID: 24072850 Free article. No abstract available.
Monoclonal gammopathy of undetermined significance: a new proposal of workup.
Mangiacavalli S, Cocito F, Pochintesta L, Pascutto C, Ferretti V, Varettoni M, Zappasodi P, Pompa A, Landini B, Cazzola M, Corso A. Mangiacavalli S, et al. Among authors: pochintesta l. Eur J Haematol. 2013 Oct;91(4):356-60. doi: 10.1111/ejh.12172. Epub 2013 Aug 17. Eur J Haematol. 2013. PMID: 23859528
15 results